Skip to main content

Table 3 CLDQ scores (mean ± SD) of chronic hepatitis B patients

From: Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls

  Overall (n = 460) Chronic hepatitis B (n = 323) Compensated cirrhosis (n = 54) Decompensated cirrhosis (n = 83)
AB* 5.5 ± 1.1 5.6 ± 1.1 5.4 ± 1.0 5.1 ± 1.2
FA 4.8 ± 1.1 4.8 ± 1.1 4.6 ± 1.1 4.6 ± 1.2
SY* 5.4 ± 0.9 5.5 ± 0.8 5.3 ± 0.8 5.0 ± 0.9
AC* 5.5 ± 1.1 5.7 ± 1.0 5.0 ± 1.2 4.8 ± 1.1
EM 4.8 ± 1.1 4.9 ± 1.1 4.7 ± 0.9 4.9 ± 1.1
WO 5.1 ± 1.2 5.0 ± 1.2 4.9 ± 1.1 5.2 ± 1.0
Overall* 5.2 ± 0.8 5.3 ± 0.8 5.0 ± 0.7 4.9 ± 0.8
  1. AB, abdominal symptoms; FA, fatigue; SY, systemic symptoms; AC, activity; EM, emotional function; WO, worry.
  2. *Significant difference among three patient groups (P < 0.05).
  3. Significantly different compared with chronic hepatitis B group (P < 0.05).